As we grow older, the risk of two different cancers looms ever larger: breast cancer for women and prostate cancer for men.
Unscrambling the Controversies:
There have been controversies over the best methods for detecting and treating each cancer. When should women start getting annual mammograms, for example? How useful are PSA screenings for identifying prostate cancer in men?
Our guests are leading experts on the treatment of these cancers, and they do not shy away from controversy. Get an update on the latest thinking on how you can cut your own risk, whether you are male or female.
The Research Articles:
The research cited on DCIS (ductal carcinoma in situ) for breast cancer was published in JAMA Oncology in October 2015. The research on prostate cancer that we discussed was published in the New England Journal of Medicine on October 29, 2015.
This Week's Guests:
is an adjunct professor of Surgery at UCLA and chief visionary officer of the Dr. Susan Love Research Foundation, a nonprofit organization dedicated to the eradication of breast cancer. You will find it online at http://drsusanloveresearch.org Dr. Love is on the board of the National Cancer Institute. Her best-selling book, Dr. Susan Love's Breast Book, is out in its 6th edition. The photograph is of Dr. Love.
Charles "Snuffy" Myers, MD, is founder and director of the American Institute for Diseases of the Prostate. He is a medical oncologist with prior experience in clinical pharmacology at the National Cancer Institute and as the director of the Cancer Center of the University of Virginia. His goal is comprehensive management of prostate cancer.
As a biochemist, I have often wondered why studies suggested that the application or injection of testosterone (a naturally occurring male hormone) could be associated with an increased risk of prostate cancer. How could a substance that one’s own body produces be dangerous to the body that produced it? Something must be amiss. Well Dr. Myers made clear what the problem is here. The adult male aging process is tied to a decreasing production of testosterone. Normal ranges for testosterone set into the computers of the testing labs are based on young men, but they do not apply to the geriatric population. Thus when a man’s own testosterone levels drop due to age, and he falls below the norms established by the millennials, he is diagnosed as suffering from “Low T” when in fact he isn’t. So adding exogenous testosterone to his daily drug intake via armpit rubs or injections endangers him, “Fuels the Fire” as Snuffy put it. Lupron is proven effective as it shuts down endogenous testosterone production. If erectile dysfunction is your problem, my suggestion is that you avoid testosterone supplementation because you want your prostate to be with you as long as possible. Go with the three mermaids of pleasure (Viagra, Levitra and Cialis) and if they prove to no avail, add the prostaglandins through Pfizer’s lovely Caverject Impulse. Don’t turbocharge your whole body by lowering its blood pressure, shoot the good medicine directly into the organ that matters, which is your penis, and satisfy the entire harem. QED